Health and Fitness Health and Fitness

Mon, February 13, 2012

[ Mon, Feb 13th 2012 ] - Market Wire

Un sondaggio mostra la richiesta di mercato per l .. ttaforma di consegna medicinali gi pronti all'uso

[ Mon, Feb 13th 2012 ] - Market Wire

Umfrage ergibt Marktnachfrage nach neuer gebrauchsfertiger Methode zur Medikamentenverabreichung

[ Mon, Feb 13th 2012 ] - Market Wire

Survey Reveals Market Demand for New Pre-filled Drug Delivery Platform

[ Mon, Feb 13th 2012 ] - Market Wire

Acorda Therapeutics Names Jane Wasman as Chief, Strategic Development

[ Mon, Feb 13th 2012 ] - Market Wire

Remedent Announces Shareholder Conference Call to Be Held on Wednesday, February 15, 2012

[ Mon, Feb 13th 2012 ] - Market Wire

Sitoa Global Announces New Marketplace With BCLN Golf

[ Mon, Feb 13th 2012 ] - Market Wire

Columbia Laboratories Transfers NDA for Progesterone Vaginal Gel 8% to Watson Pharmaceuticals

[ Mon, Feb 13th 2012 ] - Market Wire

SeraCare Announces Definitive Agreement to be Acquired by Linden Capital Partners

[ Mon, Feb 13th 2012 ] - Market Wire

STAAR Surgical Announces Fourth Quarter 2011 Results Release Date and Conference Call and Webcast

[ Mon, Feb 13th 2012 ] - Market Wire

Remedent Announces Strategic Investment by IDG-Accel

[ Mon, Feb 13th 2012 ] - Market Wire

OncoSec Initiates Phase II Merkel Cell Carcinoma Study and Doses Several Patients

[ Mon, Feb 13th 2012 ] - Market Wire

Angeion Names Todd M. Austin Executive Vice President - Global Marketing and Corporate Strategy

[ Mon, Feb 13th 2012 ] - Market Wire

The Ensign Group Acquires Portland Home Health Agency

Sun, February 12, 2012

[ Sun, Feb 12th 2012 ] - Market Wire

Shengtai Pharmaceutical Inc. Announces Results of the 2011 Annual Shareholders Meeting

Fri, February 10, 2012

[ Fri, Feb 10th 2012 ] - Market Wire

The Ensign Group Schedules Year-End 2011 Earnings Call for Thursday, February 16, 2012

[ Fri, Feb 10th 2012 ] - Market Wire

Bacterin Study at AAOS 2012 Annual Meeting Shows .. BMP-2 in Spinal Fusion;; Presented Specifi

[ Fri, Feb 10th 2012 ] - Market Wire

Mylan Intends to Challenge Unfavorable Verdict in .. n's Generic Version of Sunovion's Xopenex Inhalat

[ Fri, Feb 10th 2012 ] - Market Wire

ArthroCare Announces Date for Fourth Quarter and .. nancial Results Press Release and Conference Call

[ Fri, Feb 10th 2012 ] - Market Wire

Medivation Announces Participation at Upcoming Investor Conferences

[ Fri, Feb 10th 2012 ] - Market Wire

NuVasive Announces Conference Call and Webcast of Fourth Quarter and Full Year 2011 Results

[ Fri, Feb 10th 2012 ] - Market Wire

Exelixis Announces February 14 Webcast of Present .. tion at 14th Annual BIO CEO & Investor Conference

[ Fri, Feb 10th 2012 ] - Market Wire

Watson Confirms Beyaz(R) Patent Challenge

[ Fri, Feb 10th 2012 ] - Market Wire

Regeneron Announces February 13, 2012 as Date of .. and Operating Results Conference Call and Webcast

[ Fri, Feb 10th 2012 ] - Market Wire

Nephros, Inc. Announces Date of its 2012 Annual Meeting of Stockholders

[ Fri, Feb 10th 2012 ] - Market Wire

Cigna Corporation Announces Appearance at the Leerink Swann 2012 Global Healthcare Conference

[ Fri, Feb 10th 2012 ] - Market Wire

The Law Firm of Levi &;; Korsinsky Noti .. Their Investment in Chemed Corp. of Class Action

[ Fri, Feb 10th 2012 ] - Market Wire

Dynatronics to Release Fiscal Second Quarter Resu .. 012;; Conference Call Set for 1:30 p.m. ET

[ Fri, Feb 10th 2012 ] - Market Wire

BD to Present at Investor Healthcare Conferences

[ Fri, Feb 10th 2012 ] - Market Wire

Enzo Biochem to Present at 2012 Leerink Swann Global Healthcare Conference

[ Fri, Feb 10th 2012 ] - Market Wire

LCA-Vision to Present at the LHA Life Sciences & Medical Technologies Virtual Conference

LCA-Vision to Present at the LHA Life Sciences & Medical Technologies Virtual Conference

^{Published on 2012-02-10 09:01:23 - Market Wire}

LCA-Vision to Present at the LHA Life Sciences & Medical Technologies Virtual Conference -- CINCINNATI, Feb. 10, 2012 /PRNewswire/ --

LCA-Vision to Present at the LHA Life Sciences & Medical Technologies Virtual Conference

[ ]

CINCINNATI, Feb. 10, 2012 /PRNewswire/ -- LCA-Vision Inc. (NASDAQ: [ LCAV ]), a leading provider of laser vision correction services under the LasikPlus® brand, today announced that management will present at the LHA Life Sciences & Medical Technologies Virtual Conference on Thursday, February 16, 2012, at 10:30 a.m. Eastern time. A live and archived webcast presentation will be available at the Investor Relations section of LCA-Vision's website at [ www.lca-vision.com ].

About LCA-Vision Inc./LasikPlus®
LCA-Vision Inc., a leading provider of laser vision correction services under the LasikPlus® brand, operates 53 LasikPlus® fixed-site laser vision correction centers in 26 states and 41 markets in the United States. Additional company information is available at [ www.lca-vision.com ] and [ www.lasikplus.com ].

Earning Trust Every Moment; Transforming Lives Every Day

cellpadding="0" cellspacing="0" id="convertedTable" style="BORDER-BOTTOM: 1pt; BORDER-LEFT: 1pt; BORDER-COLLAPSE: collapse; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">

For Additional Information

Company Contact:	Investor Relations Contact:
Barb Kise	Jody Cain
LCA-Vision Inc.	LHA
513-792-9292	310-691-7100
	@LHA_IR_PR

SOURCE LCA-Vision Inc.

[ Back to top ]

RELATED LINKS
[ http://www.lca-vision.com ]

Contributing Sources

Market Wire is a Trusted Source

Market Wire